The team behind the"Dr. Death" podcast is back with another investigative miniseries,"Bad Batch," this time about a different facet of modern medicine: stem cells. The multibillion-dollar industry is very profitable but under-regulated, leaving some desperate patients vulnerable to bad treatments. "Bad Batch" premieres Wednesday, but Business Insider had the chance to listen to episode one ahead of time.
The team behind the"Dr. Death" podcast is back with another investigative miniseries,"Bad Batch," this time about a different facet of modern medicine: stem cells. The multibillion-dollar industry is very profitable but under-regulated, leaving some desperate patients vulnerable to bad treatments. "Bad Batch" premieres Wednesday, but Business Insider had the chance to listen to episode one ahead of time.